The thalamus in trigeminal neuralgia: structural and metabolic abnormalities, and influence on surgical response.
MRI
Microvascular decompression
Percutaneous rhizotomy
Spectroscopy
Thalamus
Volumetry
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
24 Jul 2021
24 Jul 2021
Historique:
received:
05
04
2021
accepted:
09
07
2021
entrez:
25
7
2021
pubmed:
26
7
2021
medline:
7
10
2021
Statut:
epublish
Résumé
Medically-refractory trigeminal neuralgia (TN) can be treated successfully with operative intervention, but a significant proportion of patients are non-responders despite undergoing technically successful surgery. The thalamus is a key component of the trigeminal sensory pathway involved in transmitting facial pain, but the role of the thalamus in TN, and its influence on durability of pain relief after TN surgery, are relatively understudied. We aimed to test the hypothesis that variations in thalamic structure and metabolism are related to surgical non-response in TN. We performed a longitudinal, peri-operative neuroimaging study of the thalamus in medically-refractory TN patients undergoing microvascular decompression or percutaneous balloon compression rhizotomy. Patients underwent structural MRI and MR spectroscopy scans pre-operatively and at 1-week following surgery, and were classified as responders or non-responders based on 1-year post-operative pain outcome. Thalamus volume, shape, and metabolite concentration (choline/creatine [Cho/Cr] and N-acetylaspartate/creatine [NAA/Cr]) were evaluated at baseline and 1-week, and compared between responders, non-responders, and healthy controls. Twenty healthy controls and 23 patients with medically-refractory TN treated surgically (17 responders, 6 non-responders) were included. Pre-operatively, TN patients as a group showed significantly larger thalamus volume contralateral to the side of facial pain. However, vertex-wise shape analysis showed significant contralateral thalamus volume reduction in non-responders compared to responders in an axially-oriented band spanning the outer thalamic circumference (peak p = 0.019). Further, while pre-operative thalamic metabolite concentrations did not differ between responders and non-responders, as early as 1-week after surgery, long-term non-responders showed a distinct decrease in contralateral thalamic Cho/Cr and NAA/Cr, irrespective of surgery type, which was not observed in responders. Atrophy of the contralateral thalamus is a consistent feature across patients with medically-refractory TN. Regional alterations in preoperative thalamic structure, and very early post-operative metabolic changes in the thalamus, both appear to influence the durability of pain relief after TN surgery.
Sections du résumé
BACKGROUND
BACKGROUND
Medically-refractory trigeminal neuralgia (TN) can be treated successfully with operative intervention, but a significant proportion of patients are non-responders despite undergoing technically successful surgery. The thalamus is a key component of the trigeminal sensory pathway involved in transmitting facial pain, but the role of the thalamus in TN, and its influence on durability of pain relief after TN surgery, are relatively understudied. We aimed to test the hypothesis that variations in thalamic structure and metabolism are related to surgical non-response in TN.
METHODS
METHODS
We performed a longitudinal, peri-operative neuroimaging study of the thalamus in medically-refractory TN patients undergoing microvascular decompression or percutaneous balloon compression rhizotomy. Patients underwent structural MRI and MR spectroscopy scans pre-operatively and at 1-week following surgery, and were classified as responders or non-responders based on 1-year post-operative pain outcome. Thalamus volume, shape, and metabolite concentration (choline/creatine [Cho/Cr] and N-acetylaspartate/creatine [NAA/Cr]) were evaluated at baseline and 1-week, and compared between responders, non-responders, and healthy controls.
RESULTS
RESULTS
Twenty healthy controls and 23 patients with medically-refractory TN treated surgically (17 responders, 6 non-responders) were included. Pre-operatively, TN patients as a group showed significantly larger thalamus volume contralateral to the side of facial pain. However, vertex-wise shape analysis showed significant contralateral thalamus volume reduction in non-responders compared to responders in an axially-oriented band spanning the outer thalamic circumference (peak p = 0.019). Further, while pre-operative thalamic metabolite concentrations did not differ between responders and non-responders, as early as 1-week after surgery, long-term non-responders showed a distinct decrease in contralateral thalamic Cho/Cr and NAA/Cr, irrespective of surgery type, which was not observed in responders.
CONCLUSIONS
CONCLUSIONS
Atrophy of the contralateral thalamus is a consistent feature across patients with medically-refractory TN. Regional alterations in preoperative thalamic structure, and very early post-operative metabolic changes in the thalamus, both appear to influence the durability of pain relief after TN surgery.
Identifiants
pubmed: 34303364
doi: 10.1186/s12883-021-02323-4
pii: 10.1186/s12883-021-02323-4
pmc: PMC8305513
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
290Informations de copyright
© 2021. The Author(s).
Références
Acta Neurochir (Wien). 2011 Dec;153(12):2365-75
pubmed: 21947457
Front Neuroanat. 2016 May 10;10:53
pubmed: 27242449
Acta Neurochir (Wien). 2019 Jul;161(7):1415-1425
pubmed: 31049710
Cephalalgia. 2019 Feb;39(2):197-208
pubmed: 29896973
NMR Biomed. 2001 Jun;14(4):260-4
pubmed: 11410943
J Neurosurg. 2014 Jun;120(6):1484-95
pubmed: 24745706
Neurosurgery. 2020 Feb 1;86(2):182-190
pubmed: 30892607
Pain. 2006 Nov;125(1-2):89-97
pubmed: 16750298
Neuroimage. 2002 Sep;17(1):479-89
pubmed: 12482100
Brain. 2016 Mar;139(Pt 3):708-22
pubmed: 26912644
Neuroimage Clin. 2017 Jun 12;15:710-718
pubmed: 28702348
Brain. 2013 Sep;136(Pt 9):2751-68
pubmed: 23983029
Pain. 2020 May;161(5):916-925
pubmed: 31842151
Neurol Res. 2008 Apr;30(3):229-33
pubmed: 17848209
Pain. 2011 Oct;152(10):2357-2364
pubmed: 21835547
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
J Neurosurg. 2019 Aug 30;:1-9
pubmed: 31470412
Neuroradiology. 2014 Aug;56(8):685-93
pubmed: 24820951
Pain. 2014 Jan;155(1):37-44
pubmed: 23999058
Cephalalgia. 2020 May;40(6):586-596
pubmed: 31752520
World Neurosurg. 2013 May-Jun;79(5-6):756-62
pubmed: 22381868
Prog Neurobiol. 2007 Feb;81(2):89-131
pubmed: 17275978
J Neurosurg. 2007 Dec;107(6):1144-53
pubmed: 18077952
Neuroimage. 2012 Aug 15;62(2):782-90
pubmed: 21979382
Clin Chem Lab Med. 2013 Mar 1;51(3):513-21
pubmed: 23314552
J Neurosurg. 1988 Jul;69(1):35-8
pubmed: 2454303
J Neurosurg. 2018 Aug 17;131(2):539-548
pubmed: 30117773
Neuroimage. 2004;23 Suppl 1:S208-19
pubmed: 15501092
Eur J Radiol. 2013 May;82(5):783-6
pubmed: 23265178
Neuroimage. 2011 Jun 1;56(3):907-22
pubmed: 21352927
Neurosurgery. 2019 Sep 1;85(3):E553-E559
pubmed: 31329945
J Neurosurg. 2019 Jul 19;:1-7
pubmed: 31323635
J Neurosci. 2011 Apr 20;31(16):5956-64
pubmed: 21508220
Cochrane Database Syst Rev. 2011 Sep 07;(9):CD007312
pubmed: 21901707
Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):1013-9
pubmed: 10863073
J Neurosurg. 2002 Mar;96(3):532-43
pubmed: 11883839